The sFlt-1/PlGF ratio did not effectively gauge future preeclampsia risk in pregnant patients with SLE and proteinuria.

Though the strategic shift allows pharma to offer integrated health solutions, diversify revenue and improve patient outcomes ...

Teva Pharmaceuticals and artificial intelligence (AI)-driven Immunai have entered into a partnership aimed at optimising ...

Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS), the leading health and wellness platform, today announced Deb Autor, ...

AstraZeneca (GB:AZN) has released an update.Don't Miss our Black Friday Offers:Discover the latest stocks recommended by top Wall Street ...

London’s FTSE 100 index is set to open 17 points higher at 8081, despite the weak handover from Wall Street’s poor ...

CHICAGO -- Researchers failed to prevent cognitive impairment in people with existing atrial fibrillation (Afib) by going the ...

Patients with GPA completely weaned off glucocorticoids were four times as likely to flare compared with those kept on a low ...

The move will be a boost for Donald Trump's incoming administration. But it will be seen as a setback for the Labour ...

For patients with previously treated EGFR-mutated NSCLC, a new BLA has been submitted to the FDA seeking the accelerated ...

Follow along for live updates on stocks, bonds and markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.